Photo from Sylvester Comprehensive Cancer Center/X
Jun 12, 2024, 06:29
Neuroendocrine tumors may respond better to an oncolytic virus plus immunotherapy – Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared on X:
“Our researchers, first author, Samuel Kareff and senior author, Aman Chauhan, found that neuroendocrine tumors with an influx of immune cells may respond better to treatment with an oncolytic virus plus immunotherapy..
Learn about their trial design.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 23:22
Nov 13, 2024, 23:18
Nov 13, 2024, 19:25
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45